← Back to Screener
Ekso Bionics Holdings, Inc. Common Stock (EKSO)
Price$18.36
Value ScoreC
Growth ScoreD
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)358.49%
Price vs S&P 500 (4W)50.75%
VGM Score55.67
Market Capitalization$42.05M
All Metrics
Book Value / Share (Quarterly)$2.54
P/TBV (Annual)5.30x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-0.29%
Cash Flow / Share (Quarterly)$-3.37
Price vs S&P 500 (YTD)101.57%
Gross Margin (TTM)53.48%
Net Profit Margin (TTM)-91.37%
EPS (TTM)$-4.95
10-Day Avg Trading Volume0.34M
EPS Excl Extra (TTM)$-4.95
Revenue Growth (5Y)7.59%
EPS (Annual)$-4.82
ROI (Annual)-89.39%
Gross Margin (Annual)53.48%
Net Profit Margin (5Y Avg)-88.26%
Cash / Share (Quarterly)$0.33
Revenue Growth QoQ (YoY)-38.31%
ROA (Last FY)-58.15%
Revenue Growth TTM (YoY)-28.60%
EBITD / Share (TTM)$-4.86
ROE (5Y Avg)-84.96%
Operating Margin (TTM)-104.12%
Cash Flow / Share (Annual)$-3.37
P/B Ratio4.66x
P/B Ratio (Quarterly)3.25x
Net Income / Employee (Annual)$-233,900
EV / Revenue (TTM)3.51x
Net Interest Coverage (TTM)-8.18x
ROA (TTM)-50.71%
EV / EBITDA (TTM)1.01x
EPS Incl Extra (Annual)$-4.82
Current Ratio (Annual)1.63x
Quick Ratio (Quarterly)0.98x
3-Month Avg Trading Volume0.17M
52-Week Price Return304.41%
Revenue / Employee (TTM)$256,000
Tangible BV / Share (Quarterly)$1.55
P/S Ratio (Annual)3.29x
Asset Turnover (Annual)0.64x
52-Week High$20.70
Operating Margin (5Y Avg)-95.89%
EPS Excl Extra (Annual)$-4.82
CapEx CAGR (5Y)-9.22%
Tangible BV CAGR (5Y)0.06%
26-Week Price Return374.42%
Quick Ratio (Annual)0.98x
13-Week Price Return83.23%
Total Debt / Equity (Annual)0.45x
Current Ratio (Quarterly)1.63x
Enterprise Value$44.93M
Revenue / Share Growth (5Y)33.59%
Asset Turnover (TTM)0.56x
Book Value / Share Growth (5Y)36.68%
Revenue / Employee (Annual)$256,000
Inventory Turnover (Annual)1.27x
Pretax Margin (Annual)-91.37%
Cash / Share (Annual)$0.33
3-Month Return Std Dev92.78%
Gross Margin (5Y Avg)52.86%
Net Income / Employee (TTM)$-233,900
ROE (Last FY)-129.56%
Net Interest Coverage (Annual)-34.23x
EPS Basic Excl Extra (Annual)$-4.82
Receivables Turnover (TTM)1.76x
Total Debt / Equity (Quarterly)0.45x
EPS Incl Extra (TTM)$-4.95
Receivables Turnover (Annual)1.76x
ROI (TTM)-77.87%
P/S Ratio (TTM)3.29x
Pretax Margin (5Y Avg)-88.26%
Revenue / Share (Annual)$5.28
Tangible BV / Share (Annual)$1.55
Price vs S&P 500 (52W)276.20%
Year-to-Date Return112.50%
5-Day Price Return18.57%
EPS Normalized (Annual)$-4.82
ROA (5Y Avg)-41.99%
Net Profit Margin (Annual)-91.37%
Month-to-Date Return52.87%
Cash Flow / Share (TTM)$-1.03
EBITD / Share (Annual)$-4.85
Operating Margin (Annual)-104.12%
LT Debt / Equity (Annual)0.09x
ROI (5Y Avg)-61.41%
LT Debt / Equity (Quarterly)0.09x
EPS Basic Excl Extra (TTM)$-4.95
P/TBV (Quarterly)5.30x
P/B Ratio (Annual)3.25x
Inventory Turnover (TTM)1.27x
Pretax Margin (TTM)-91.37%
Book Value / Share (Annual)$2.54
Price vs S&P 500 (13W)73.49%
Beta1.01x
Revenue / Share (TTM)$3.99
ROE (TTM)-110.52%
52-Week Low$2.73
vGradeC
gGradeD
mGradeA
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-2.04est. -0.23
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.00
4.00
4.00
4.00
Industry Peers — General Industrial Machinery(16)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
EKSOEkso Bionics Holdings, Inc. Common Stock | C | D | A | $18.36 |
| SYMSymbotic Inc. Class A Common Stock | F | A | D | $48.40 |
| NDSNNordson Corp | C | C | C | $281.31 |
| RRXRegal Rexnord Corporation | C | C | C | $202.09 |
| ESABESAB Corporation | C | D | F | $90.43 |
| ATSATS Corporation | C | C | D | $29.50 |
| OUSTOuster, Inc. | F | A | A | $44.93 |
| SERVServe Robotics Inc. Common Stock | D | A | D | $9.42 |
| RRRichtech Robotics Inc. Class B Common Stock | D | D | C | $3.10 |
| AZA2Z Cust2Mate Solutions Corp. Common Shares | F | A | C | $6.87 |
| TAYDTaylor Devices Inc | C | C | D | $53.08 |
About
Ekso Bionics designs and manufactures wearable exoskeletons that augment human strength, endurance, and mobility in healthcare and industrial applications. The company operates two business segments—Enterprise Health and Personal Health—serving customers across the Americas, EMEA, and APAC regions. All operations are based in the United States.